Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease. - Wikidata - wikimedia - TriplyDB

Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease.

Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease.

http://www.wikidata.org/entity/Q38923188

about

Arbovirosis and potential transmission blocking vaccines The re-emerging arboviral threat: Hidden enemies Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses Historical Perspectives on Flavivirus Research A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound The potential role of Wolbachia in controlling the transmission of emerging human arboviral infections An update on Zika vaccine developments.Iminosugar antivirals: the therapeutic sweet spot.Human macrophages differentiated in the presence of vitamin D3 restrict dengue virus infection and innate responses by downregulating mannose receptor expression.A review of selected Arboviruses during pregnancy.NS3 helicase from dengue virus specifically recognizes viral RNA sequence to ensure optimal replication.A universal mammalian vaccine cell line substrate.Towards the Application of Human Defensins as Antivirals.Limiting global-mean temperature increase to 1.5-2 °C could reduce the incidence and spatial spread of dengue fever in Latin America.Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone

P2860

Q27468657-28A22DB8-3F2B-4861-A078-99F8457639B3 Q28114692-A00B965E-8F44-4C19-8A9C-5582DD5D5D6E Q28577861-768320EE-8038-4B87-BC9C-B09FC15E2AB7 Q29994534-FFE67973-1B59-4112-BDDB-B7CD76923121 Q33918841-BFACCAAC-1EFA-4E6D-A5CC-7206ABD6CE7C Q37665028-826AB698-3B96-4998-8BEE-77F65037C0EF Q38158670-6EAE18AC-DA62-4127-B471-36C2A1355DD1 Q38730551-A646B626-D84E-486C-9C3E-737DA1895F9F Q41919265-498CD34D-AEF0-4029-AE35-7B265D4F0C4C Q42284528-2AD13138-4F68-4E72-9C69-8E13E8524FAB Q45324413-CB095CC6-DCB6-46D9-94EC-09429E5DB131 Q47143756-5363505D-FE62-4883-BC1A-706FBEB3A15B Q47557198-109EE7A0-4CF3-478C-88B4-AC52417D0B0A Q55311653-EFF189BC-CDC3-4DAA-9474-9E85FA244D78 Q56986149-C2A61627-85D8-4EA2-91E5-492C62DF7006

P2860

Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease.

http://www.wikidata.org/entity/Q38923188

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease.

@en

type

label

Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease.

@en

prefLabel

Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease.

@en

P1433

Q38923188-E6A199F1-6C3C-4526-A70C-5B38E39AC654

P1476

Q38923188-7942C6BE-E554-4A31-8845-925E35218296

P2860

Q38923188-0436B0C5-8A71-41FC-A805-6BE6A026C777

Q38923188-0A48FA5B-5314-4EB7-969A-6C4CECE30EF0

Q38923188-12E72542-A5AF-4412-82E2-028CA3B6C807

Q38923188-144D3A25-95DB-4AD6-B27A-FB65D1BEEDA1

Q38923188-1596D504-147D-4CA9-87BC-24C9B9B9BFEE

Q38923188-17695FEF-2911-49DA-9361-5AF0AF590095

Q38923188-179E6430-DA06-4D1B-A073-C28C44A6AB8E

Q38923188-1893BA1D-F334-414F-8877-D3D6D8AB3AF3

Q38923188-22BF9717-CB0D-48AF-9F0E-ECFD50EF7D38

Q38923188-24745CE6-AE77-4363-BC05-4FB8BB2F3AE5

P2888

Q38923188-B2F462E7-5758-414E-9709-6E82C37B7211

P304

Q38923188-B328FE47-C13B-4E10-A03C-2A7F13DBB917

P31

Q38923188-FAC6EFD5-A7C3-490E-9685-707042CFEC09

P356

Q38923188-E7ABAFE4-3962-484C-AE58-F74D9E9E31FC

P433

Q38923188-DFB917DF-D0E4-4A43-B654-9211A328A44F

P478

Q38923188-079B1DB9-E7D3-467B-AD80-A7E6D0579D07

P50

Q38923188-3248C58F-F925-4978-8D78-60601EB5BEB6

P577

Q38923188-EEE6BEE6-8E9A-4968-8840-391338C8CEEE

P6179

Q38923188-3CAF898D-2C3C-4083-996F-8F5B4905C22F

P698

Q38923188-4AE873F0-1584-462D-BF81-23F038A08C65

P921

Q38923188-C5A57CB1-EDF7-4EE7-A3A3-D4496DF2637C

P356

S40265-016-0626-8

P1433

P1476

Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease.

@en

P2860

Tackling dengue fever: Current status and challenges

The global distribution and burden of dengue

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

A critical assessment of vector control for dengue prevention

Epidemiology of dengue disease in the Philippines (2000-2011): a systematic literature review

Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial

Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Potential opportunities and perils of imperfect dengue vaccines.

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.

P2888

s40265-016-0626-8

P304

1301-1312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-016-0626-8

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1000909269

http://www.w3.org/2001/XMLSchema#string

P698

27506852

http://www.w3.org/2001/XMLSchema#string

P921